Dr. Sherry Boodram is the CEO and Co-Founder of CannDelta Inc., a leading regulatory and scientific cannabis and psychedelics consulting firm that specializes in licensing and compliance support across North America.
Sherry is an industry leader who regularly contributes to media and speaking forums, having gained prominent experience over several years in the Canadian federal government, most notably at Health Canada’s Medical Cannabis and Controlled Substances Programs as a Senior Regulatory Compliance and Enforcement Officer.
Sherry has extensive knowledge and experience in compliance and licensing submissions, new technology compliance, international policy and regulation development, mergers and acquisitions, due diligence inspections and audits, internal quality management systems and processes, facility design, operational optimization, and education.
Sherry is an independent board advisor of a publicly traded cannabis company and elected board member for the Canadian Association for Professionals in Regulatory Affairs (CAPRA). She holds a Ph.D. in Chemistry from York University, a Hon. B.Sc. in Biological Chemistry from the University of Toronto, a Certificate in Cannabis Law and Regulation from Osgoode Hall Law School of York University, and a Graduate Certificate with Honours in Pharmaceutical Regulatory Affairs and Quality Operations from Seneca College.